Researchers sought to determine whether combining enasidenib with venetoclax would be effective in patients with IDH2-mutated ...
First MIRACLE trial unblinding expected Q1 2026; Global trial now spans nine countries – Investigator-Initiated (IIT) funded ...
Niktimvo™ (axatilimab-csfr) 4Q25 and full year 2025 net revenue, respectively; Syndax will report its share of the Niktimvo net profit when it reports full year 2025 results – – Ended 2025 with ...
First MIRACLE trial unblinding expected Q1 2026; Global trial now spans nine countries - Investigator-Initiated (IIT) funded pancreatic and brain cancer trials HOUSTON, Jan. 12, 2026 (GLOBE NEWSWIRE) ...
Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today provided a business update including preliminary total revenue and net product ...
The House passed a bill last week that would “repurpose” $500 million meant for cleaning up environmental and safety hazards ...
DMR-001, a potentially best-in-class mutant calreticulin (“mutCALR”) targeting monoclonal antibody, on track for expected IND submission, or ...
ST. LOUIS -- Al Arbour, Barret Jackman, and Alexander Steen became the fourth class inducted into the St. Louis Blues Hall of ...
First Onsite, which specializes in restoration and risk mitigation, provides services to minimize losses from events such as ...
RENO, Nev. (KOLO) - Nicole Tomaino is the owner of V acations By Nicole & Associates, LLC. This Thursday, Jan. 15, she is ...
Dubai regulator updates DIFC crypto rules, limiting privacy coins, tightening stablecoin definitions, and adjusting ...
Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback